Enclosed herewith Outcome of the Board Meeting.

Date: November 07, 2026 The Manager, Listing Department, BSE Limited, P. J. Tower, Dalal Street, Mumbai – 400 001 Scrip Code: 530825 Security ID: DAIKAFFI Sub: Outcome of the Board Meeting in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”): Dear Sir/Ma'am, The Board of Directors of the Company at its meeting held today, i.e., November 07, 2026, has, inter alia, considered and approved the following: 1. Financial Results: Pursuant to Regulation 33 of Listing Regulations, The Board considered and approved the Un-audited Financial Results for the quarter and half year ended September 30, 2026 together with Limited Review Report thereon. Please find enclosed herewith the Un-audited Financial Result for the quarter and half year ended September 30, 2026 together with Limited Review Report of Auditor thereon; An extract of the aforementioned results would be published in the newspaper in accordance with the Listing Regulations. The Financial Result will also be available on the website of the Company at www.daikaffil.com and also on website of BSE Ltd at www.bseindia.com. The meeting commenced at 10:30 am and concluded at 11:45 am. Kindly take the same on your records and acknowledge the receipt of same. Thanking You. Yours faithfully, For Daikaffil Chemicals India Limited Jay Chandu Patel Company Secretary and Compliance Officer M. No.: A73587 N V C & Associates LLP Chartered Accountants 903-904, 9th Floor, Raheja Chambers, 213, Nariman Point, Mumbai 400 021. Tel.: (91-22) 6752 7100 Email : nve@nvc.in LLPIN - ACM-9656 Independent Auditor’s Review Report on Standalone Unaudited Financial Results for the gquarter and half year ended on September 30, 2026, of Daikaffil Chemicals India Limited, bursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) The Board of Directors of Daikaffil Chemicals India Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results (“the Statement”) of Daikaffil Chemicals India Limited (“the Company”) for the quarter and half year ended September 30, 2026, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) “Listing Regulations”, including relevant circulars issued by the SEBI from time to time. 2. Management’s Responsibility The Statement is the responsibility of the Company’s Management and has been approved by the Board of Directors. This statement has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (Ind-AS 34) prescribed under section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion in our report on this statement of standalone unaudited financial results based on our review. 3. Auditor’s Responsibility We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatements. A review of interim financial information consists of making inquiries, primarily of persons responsible for accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in NV C & Associates LLP Chartered Accountants 903-904, 9th Floor, Raheja Chambers, 213, Nariman Point, Mumbai 400 021. Tel.: (91-22) 6752 7100 Email : nve@nvc.in LLPIN - ACM-9656 accordance with Standards of Auditing and conseq uently does not enable us to obtain ia ds es nu tr ia fin ec de it h aa nt aw ue o Wul ed hb ae vec o nm oe pa ew ra fr oe mo ef a all s ai ug dn ii tfi aca nn dt m aa ct cot re dr is gt lh ya ,t m ei g dh ot nb ote express an audit opinion. 4. Conclusion Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement of standalone unaudited financial results, preparedrin accordance with applicable accounting standards as specified under section 133 of the Companies Act, 2013, read with rule 7 of the Companies (Accounts) Rules, 2014 and other recognized accounting practices and policies, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEB| (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended including the manner in which it is to be disclosed, or that it contains any material misstatement. For NV C & Associates LLP Chartered Accountants FRN. 106971W/ W101085 N Jayendran Partner M. No. 040441 Mumbai, Dated: November 07,2026 UDIN: 26040441EKOKZ)2903 DAIKAFFIL CHEMICALS INDIA LIMITED Regd. Office : E-4, M.1.D.C., Tarapur, Dist-Palghar, Maharashtra - 401506 Tel. No.: 02525-272674 Corporate Office: 2nd Floor, A Wing, Fortune Avirahi, Jain Derasar Road, Borivali-West, Mumbai-400092, CIN: L24114MH1992PLC067309 Tel. No.: +91 22 5070 5050 Email: cs@daikaffil.com Website: www.daikaffil.com Statement of Unaudited Standalone Financial Results for the Quarter and Half Year Ended September 30, 2026 ( All figures are Rupees in Lakhs unless otherwise Stated ) Quarter Ended Six month ended Year Ended Sl Particulars 30.09.2026 | 30.06.2026 | 30.09.2025 | 30.09.2026 | 30.09.2025 | 31.03.2026 Ne- Unaudited | Unaudited | Unaudited | Unaudited | Unaudited [ Audited 1 | Income (a) Revenue from Operations 224.88 102.98 603.60 327.86 991.29 1,334.75 (b) Other Income ¢ 0.66 0.73 1.35 1.39 2.23 5.31 Total Income 225.54 103.71 604.95 329.25 993.52 1,340.06 2 | Expenses (a) Cost of materials consumed 113.79 113.96 202.63 227.75 822.35 978.64 (b) Ch.anges in Inventories of Finished Goods and 72.00 (70.08) 389.16 193 (44.86) (8.35) Work-in-Progress (c) Employee Benefits Expense 53.17 41.52 43.14 94.69 81.04 172.16 (d) Finance Costs 0.36 0.47 0.03 0.83 0.64 0.81 (e) Depreciation and Amortisation Expense 717 7.65 8.42 14.82 18.13 36.43 (f) Other Expenses 45.84 73.82 95.63 119.66 208.31 378.65 Total Expenses 292.33 167.34 739.07 459.68 1,085.61 1,558.34 3 | Profit/(Loss) before Exceptional Item and Tax (1-2) (66.79) (63.63)| (134.12)] (130.43)| (92.09)] (218.28) 4 | Exceptional Items N - - - - - 5 | Profit/(Loss) before Tax (3+4) (66.79) (63.63)| (134.12)] (130.43) (92.09) (218.28) 6 | Tax Expenses/(Credit) (a) Current Tax - - - BE - (b) Deferred tax cha/r (crgediet) (1.30) (0.90) (0.39) (2.20) (0.83) (4.21) (c) Tax Adjustment of earlier periods (0.04) B - (0.04)[ - B Total Tax Expenses (1.34) (0.90) (0.39) (2.28) (0.83) (4.21) 7 | Profit/ (Loss) for the Period after Taxes (5-6) (65.45) (62.73)| (133.73)] (128.19) (91.26)] (214.06) 8 | Other Comprehensive Income (net of Taxes) (a) Items that will not be reclassified to profit or loss (net of tax) (0.66) 0.68 (1.79) 0.02 (3.58) 2.63 (b) Items that will be reclassified to profit or loss (net of tax) . . . . l ) Total Other Comprehensive Income (net of Taxes) (0.66) 0.68 (1.79) 0.02 (3.58) 2.63 9 [ Total Comprehensive Income for the period (7+8) (66.11) (62.05)| (135.52)] (128.17) (94.88)] (211.44) 10 | Paid up Equity Share Capital (Face value of Rs.10 per share - each fully paid up) 600.00 600.00 600.00 600.00 600.00 600.00 11 | Other Equity - N B B - 73.77 12 | Earning per share (not annualised for the quarters) (a) Basic (1.09) (1.05) (2.23) (3.57) {b) Diluted (1.09) {1.05) (2.23) (3.57) DAIKAFFIL CHEMICALS INDIA LIMITED Regd. Office : E-4, M.LD.C., Tarapur, Dist-Palghar, Maharashtra - 401506 Tel. No.: 02525-272674 Corporate Offic [Showing first 8,000 characters — download PDF for full document]